Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$104.0 - $122.92 $438,464 - $518,230
4,216 Added 109.19%
8,077 $938,000
Q4 2022

Feb 10, 2023

SELL
$84.98 - $122.67 $34,161 - $49,313
-402 Reduced 9.43%
3,861 $437,000
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $325,480 - $401,489
4,263 New
4,263 $343,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Exos Tfp Holdings LLC Portfolio

Follow Exos Tfp Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exos Tfp Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exos Tfp Holdings LLC with notifications on news.